185 related articles for article (PubMed ID: 38835014)
1. Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.
Chan AML; Ng AMH; Yunus MHM; Idrus RH; Law JX; Yazid MD; Chin KY; Yusof MRM; Ng SN; Koh B; Lokanathan Y
Stem Cell Res Ther; 2024 Jun; 15(1):160. PubMed ID: 38835014
[TBL] [Abstract][Full Text] [Related]
2. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
3. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
[TBL] [Abstract][Full Text] [Related]
5. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
6. Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton's jelly in the treatment of streptozotocin-induced diabetic rats.
El-Hossary N; Hassanein H; El-Ghareeb AW; Issa H
Diabetes Res Clin Pract; 2016 Nov; 121():102-111. PubMed ID: 27693839
[TBL] [Abstract][Full Text] [Related]
7. Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model.
Hu J; Wang Y; Wang F; Wang L; Yu X; Sun R; Wang Z; Wang L; Gao H; Fu Z; Zhao W; Yan S
Endocrine; 2015 Feb; 48(1):124-34. PubMed ID: 24590294
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
12. Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.
Yu HR; Huang HC; Chen IL; Li SC
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731977
[TBL] [Abstract][Full Text] [Related]
13. Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.
Musiał-Wysocka A; Kot M; Sułkowski M; Majka M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540534
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats.
Gao LR; Zhang NK; Zhang Y; Chen Y; Wang L; Zhu Y; Tang HH
Stem Cell Res Ther; 2018 Dec; 9(1):339. PubMed ID: 30526660
[TBL] [Abstract][Full Text] [Related]
15. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
16. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
[TBL] [Abstract][Full Text] [Related]
19. A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.
Liu X; Zheng P; Wang X; Dai G; Cheng H; Zhang Z; Hua R; Niu X; Shi J; An Y
Stem Cell Res Ther; 2014 Apr; 5(2):57. PubMed ID: 24759263
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
